European regulator approves Pfizer vaccine for children aged 12-15

The European Medicines Agency has recommended the use of the vaccine made by Pfizer and BioNTech be expanded to children aged 12 to 15, offering younger and less at-risk populations across the continent access to a Covid-19 jab for the first time during the pandemic.